Clinical Trial Update: Cell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples

View source ↗

Summary

This clinical trial is investigating cell-surface plectin as a diagnostic biomarker for cholangiocarcinoma using ERCP-derived biliary samples; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Snippet

Sponsor: University of Virginia | Conditions: Cholangiocarcinoma | Status: NOT_YET_RECRUITING